Abstract
Letters and Corrections1 April 1979Valproic Acid BibliographyJ. KIFFIN PENRY, M.D.J. KIFFIN PENRY, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-90-4-724_1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: Valproic acid (Depakene®) is a newly approved drug for the treatment of seizures. Its availability is a significant advance because valproic acid is effective in many types of seizures and is relatively free of serious side effects. The Epilepsy Branch of the National Institute of Neurological and Communicative Disorders and Stroke (NINCDS) has prepared a classified bibliography on valproic acid to aid in its continued investigation and its application to clinical practice.Copies of this publication are available at no cost from the Office of Scientific and Health Reports, NINCDS, National Institutes of Health, Building 31, Room... This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: National Institute of Neurological and Communicative Disorders and Stroke Bethesda, MD 20014 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 April 1979Volume 90, Issue 4Page: 724-724KeywordsDrugsEpilepsyEpileptic seizuresStroke Issue Published: 1 April 1979 PDF downloadLoading ...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
